Gemini Therapeutics, Inc. /DE·4

Oct 6, 4:15 PM ET

Ong Tuyen 4

4 · Gemini Therapeutics, Inc. /DE · Filed Oct 6, 2021

Insider Transaction Report

Form 4
Period: 2021-10-04
Ong Tuyen
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-10-04+17,24517,245 total
    Exercise: $3.80Exp: 2031-10-03Common Stock (17,245 underlying)
Footnotes (1)
  • [F1]This option shall vest and become exercisable on the earlier of (a) the one (1)-year anniversary of the Grant Date and (b) the Company's next annual meeting of stockholders, in each case, so long as the Optionee continues to have a Service Relationship with the Company on such date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION